4//SEC Filing
Burgess Paul D. 4
Accession 0000950170-23-032016
CIK 0001805387other
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 4:16 PM ET
Size
8.0 KB
Accession
0000950170-23-032016
Insider Transaction Report
Form 4
Burgess Paul D.
See Remarks
Transactions
- Award
Restricted Stock Units
2023-07-03+23,847→ 23,847 total→ Common Stock (23,847 underlying) - Award
Stock Option (Right to Buy)
2023-07-03+95,931→ 95,931 totalExercise: $31.45Exp: 2033-07-03→ Common Stock (95,931 underlying)
Footnotes (2)
- [F1]25% of this option shall vest and become exercisable on July 3, 2024, with the remainder vesting in thirty-six (36) monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
- [F2]The shares reported in this transaction represent Restricted Stock Units ("RSUs") granted under the Cerevel Therapeutics Holdings, Inc. 2020 Equity Incentive Plan (the "Plan"). Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs vest in four equal annual installments on each of July 3, 2024, July 3, 2025, July 3, 2026 and July 3, 2027, subject to the Reporting Person's continued service on each such vesting date.
Documents
Issuer
Cerevel Therapeutics Holdings, Inc.
CIK 0001805387
Entity typeother
Related Parties
1- filerCIK 0001744627
Filing Metadata
- Form type
- 4
- Filed
- Jul 5, 8:00 PM ET
- Accepted
- Jul 6, 4:16 PM ET
- Size
- 8.0 KB